Gene · 51206
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Restraining of glycoprotein VI- and integrin α2β1-dependent thrombus formation by platelet PECAM1. | Cell Mol Life Sci | 2024 | 38236412 | PubTator, text mining | PubMed |
| Downscaling platelet cryopreservation: Are platelets frozen in tubes comparable to standard cryopreserved platelets? | Transfusion | 2024 | 38230448 | PubTator, text mining | PubMed |
| Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia. | Res Pract Thromb Haemost | 2024 | 38226339 | PubTator, text mining | PubMed |
| Work-Related Musculoskeletal Disorders Risk Assessment during Manual Lymphatic Drainage with Compressive Bands among Physiotherapists. | Healthcare (Basel) | 2024 | 38201023 | PubTator, text mining | PubMed |
| Structures and diversities of bacterial communities in oil-contaminated soil at shale gas well site assessed by high-throughput sequencing. | Environ Sci Pollut Res Int | 2024 | 38200199 | PubTator, text mining | PubMed |
| Platelets from patients with chronic inflammation have a phenotype of chronic IL-1β release. | Res Pract Thromb Haemost | 2024 | 38192728 | PubTator, text mining | PubMed |
| Antiplatelet activity and toxicity profile of novel phosphonium salts derived from Michael reaction. | Eur J Pharm Sci | 2024 | 38181870 | PubTator, text mining | PubMed |
| A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene. | Thromb J | 2024 | 38169400 | PubTator, text mining | PubMed |
| NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer. | J Exp Clin Cancer Res | 2024 | 38167224 | PubTator, text mining | PubMed |
| Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke. | J Nanobiotechnology | 2024 | 38166940 | PubTator, text mining | PubMed |
| Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective. | Drug Deliv | 2024 | 38147501 | PubTator, text mining | PubMed |
| Revealing profile of cancer-educated platelets and their factors to foster immunotherapy development. | Transl Oncol | 2024 | 38134841 | PubTator, text mining | PubMed |
| Investigation of the role of von Willebrand factor in shear-induced platelet activation and functional alteration under high non-physiological shear stress. | Artif Organs | 2024 | 38112069 | PubTator, text mining | PubMed |
| A prophage encoded ribosomal RNA methyltransferase regulates the virulence of Shiga-toxin-producing Escherichia coli (STEC). | Nucleic Acids Res | 2024 | 38084890 | PubTator, text mining | PubMed |
| The platelet storage lesion, what are we working for? | J Clin Lab Anal | 2024 | 38069592 | PubTator, text mining | PubMed |
| Diphenyl-tetrazol-propanamide Derivatives Act as Dual-Specific Antagonists of Platelet CLEC-2 and Glycoprotein VI. | Thromb Haemost | 2024 | 37967855 | PubTator, text mining | PubMed |
| Platelet Metabolic Profiling Reveals Glycolytic and 1-Carbon Metabolites Are Essential for GP VI-Stimulated Human Platelets-Brief Report. | Arterioscler Thromb Vasc Biol | 2024 | 37942614 | PubTator, text mining | PubMed |
| Platelet biology and function: plaque erosion vs. rupture. | Eur Heart J | 2024 | 37940193 | PubTator, text mining | PubMed |
| Modelling arterial thrombus formation in vitro. | Curr Opin Hematol | 2024 | 37823547 | PubTator, text mining | PubMed |
| Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2, and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand. | J Thromb Haemost | 2024 | 37813196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51206/papers?page=11